| Author, year | | Type of animal | Type of injury | MSC type | Number of MSC | Route of delivery | Endpoints for this meta-analysis |
| Herrera 2004 | 24 | Mice | Glycerol-induced | BM-MSCs | | Intravenous injection | Scr | Bi 2007 | 12 | Mice | Cisplatin-induced | BM-MSCs | | Intravenous injection or intraperitoneal injection | Scr, BUN | Sun 2008 | 40 | Rat | Glycerol-induced | BM-MSCs | | Abdominal aorta injection | Scr, BUN | Qian 2008 | 6 | Rat | Glycerol-induced | BM-MSCs | | Intravenous injection | Scr | Magnasco 2008 | 22 | Rat | Adriamycin-induced | BM-MSCs | | Intravenous injection | Scr, BUN, UAE, renal damage score | Bruno 2009 | 16 | Mice | Glycerol-induced | BM-MSCs | — | Intravenous injection | Scr, BUN, MDA, GSH, SOD, renal damage score | Eliopoulos 2010 | 10 | Mice | Cisplatin-induced | BM-MSCs | | Intraperitoneal injection | Scr, BUN | Kim 2012 | 17 | Rat | Cisplatin-induced | AD-MSCs | | Intravenous injection | Scr, BUN | Zickri 2012 | 30 | Rat | Adriamycin-induced | hUC-MSCs | | Intravenous injection | Scr | Sarhan 2014 | 19 | Rat | Adriamycin-induced | BM-MSCs | | Intravenous injection | Scr, BUN, UAE, renal pathology, MDA, GSH | Moustafa 2016 | 80 | Rat | Cisplatin-induced | BM-MSCs | | Intravenous, intraarterial or kidney subcapsular injection | Scr, MDA, GSH, SOD | Elhusseini 2016 | 40 | Rat | Cisplatin-induced | AD-MSCs | | Intravenous injection | Scr, BUN, Ccr, renal pathology, MDA, GSH, SOD | Anan 2016 | 13 | Rat | Adriamycin-induced | BM-MSCs | | Intravenous injection | Scr, BUN, SOD | Gad 2017 | 24 | Rat | Methotrexate-induced | BM-MSCs | | Intraperitoneal injection | Scr, BUN, MDA, GSH | Rashed 2018 | 20 | Rat | Streptozotocin -induced | BM-MSCs | | Intravenous injection | Scr, BUN, UAE, Ccr | Elbaghdady 2018 | 20 | Rat | Cadmium chloride-induced | BM-MSCs | | Intravenous injection | Scr | Danjuma 2018 | 16 | Rat | Rifampicin-induced | BM-MSCs | | Intravenous injection | Scr, BUN | Putra 2019 | 10 | Rat | Gentamicin induced | hUC-MSCs | | Intraperitoneal injection | Scr, BUN, renal pathology | Cetinkaya 2019 | 17 | Rat | Aristolochic acid induced | hAMSC | | Intravenous injection | Scr, BUN | Selim 2019 | 70 | Rat | Cisplatin-induced | AD-MSCs; BM-MSCs | | Intravenous injection | Scr, BUN | Mata-Miranda 2019 | 10 | Mice | Cisplatin-induced | mESCs | | Intraperitoneal injection | Scr | Vazquez-Zapien 2019 | 19 | Mice | Cisplatin-induced | mESCs | | Intraperitoneal injection | Scr | Minocha 2019 | 3 | Rat | Cisplatin-induced | AFSC | | Intravenous injection | Scr, BUN | Sun B 2019 | 10 | Rat | Cisplatin-induced | USCs | | Intravenous injection | Scr | Sun 2019 | 6 | Rat | Cisplatin-induced | BM-MSCs | — | Renal parenchyma injection | Scr, BUN | Zhang 2020 | 9 | Rat | Cisplatin-induced | USCs | | Subcutaneous injection | Scr, Ccr, renal pathology | Foroutan 2020 | 6 | Rat | Cisplatin-induced | BM-MSCs | — | Intraperitoneal injection | Scr, BUN |
|
|